New light therapy could zap skin cancer without surgery
NCT ID NCT03573401
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 3 trial tests whether a gel called Ameluz® combined with a special red light can effectively treat superficial basal cell carcinoma, a common skin cancer. About 187 adults with at least one lesion are enrolled. The main goal is to see if the treated skin cancer clears up both visually and under a microscope 12 weeks after the last treatment session.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ameluz® (BF-200 ALA) and BF-RhodoLED® lamp
What this could lead to
If successful, this could provide a non-surgical treatment option for superficial basal cell carcinoma, potentially reducing the need for surgery.
What could go wrong
This is a Phase 3 trial, but results are not yet published. The treatment may not be more effective than placebo, and side effects like skin reactions are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUPERFICIAL BASAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AboutSkin Research, LLC
Greenwood Village, Colorado, 80111, United States
-
Alliance Dermatology & Mohs Center
Phoenix, Arizona, 85032, United States
-
Austin Institute for Clinical Research Inc.
Houston, Texas, 77056, United States
-
Austin Institute for Clinical Research Inc.
Pflugerville, Texas, 78660, United States
-
Clinical Research Center of the Carolinas
Charleston, South Carolina, 29407, United States
-
Cosmetic Laser Dermatology
San Diego, California, 92121, United States
-
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
-
Dermatology Associates PA of the Palm Beaches
Delray Beach, Florida, 33445, United States
-
First OC Dermatology
Fountain Valley, California, 92708, United States
-
Henry Ford Health System
Detroit, Michigan, 48202, United States
-
Jordan Valley Dermatology
West Jordan, Utah, 84088, United States
-
Laser and Skin Surgery Center of Indiana
Indianapolis, Indiana, 46260, United States
-
Medical Dermatology Specialists
Phoenix, Arizona, 85006, United States
-
Rochester Dermatologic Surgery
Victor, New York, 14564, United States
-
Skin Search of Rochester, Inc
Rochester, New York, 14623, United States
-
The Narrows Institute for Biomedical Research and Education, Inc.
Brooklyn, New York, 11209, United States
-
University of Florida Dept of Dermatology
Gainesville, Florida, 32606, United States
-
Virginia Clinical Research, Inc.
Norfolk, Virginia, 23502, United States